The trademark application AMVYTTRA was filed by Alnylam Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on October 1, 2020, and it was registered by office on January 8, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and address of the trademark registration was recorded on December 1, 2022.